Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact
- PMID: 39816249
- PMCID: PMC11732074
- DOI: 10.3389/frabi.2024.1405401
Prescriptive appropriateness of dalbavancin in acute bacterial skin and skin structure infections in adults: an integrated approach between clinical profile, patient- and health system-related factors and focus on environmental impact
Keywords: ABSSSIs; MRSA; antibiotic therapy; clinical efficacy; dalbavancin; patient compliance; pharmacoeconomics.
Conflict of interest statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.Expert Rev Anti Infect Ther. 2022 Nov;20(11):1477-1489. doi: 10.1080/14787210.2021.1828865. Epub 2020 Oct 21. Expert Rev Anti Infect Ther. 2022. PMID: 32981375
-
The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs).Expert Rev Anti Infect Ther. 2020 May;18(5):415-422. doi: 10.1080/14787210.2020.1746643. Epub 2020 Mar 29. Expert Rev Anti Infect Ther. 2020. PMID: 32223465 Review.
-
Cost-Consequence Analysis of Single-Dose Dalbavancin Versus Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections in a Multisite Healthcare System.Clin Infect Dis. 2021 Oct 5;73(7):e1436-e1442. doi: 10.1093/cid/ciaa1732. Clin Infect Dis. 2021. PMID: 33211794
-
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries.Clin Drug Investig. 2020 Apr;40(4):305-318. doi: 10.1007/s40261-020-00891-w. Clin Drug Investig. 2020. PMID: 32034687
-
Dalbavancin for the treatment of acute bacterial skin and skin structure infections.Infez Med. 2015 Dec;23(4):313-7. Infez Med. 2015. PMID: 26700080 Review.
References
-
- Agenzia Nazionale per i Servizi Sanitari (2022) Il personale del Servizio Sanitario Nazionale. Available online at: https://www.agenas.gov.it/images/agenas/In%20primo%20piano/personale/per....
-
- Caselli D., Mariani M., Colomba C., Ferrecchi C., Cafagno C., Trotta D., et al. . (2024). Real-world use of dalbavancin for treatment of soft tissue and bone infection in children: safe, effective and hospital-time sparing. Children (Basel). 11, 78. doi: 10.3390/children11010078 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources